Hyun Jeong Kwak
Incheon, South Korea
NCT Number: NCT01443962
During the laparoscopic cholecystectomy, Pneumoperitoneum could affect to the regional oxygen saturation of brain. positive end expiratory pressure (PEEP)could improve the respiratory parameters include oxygenation. So applying PEEP could improve the regional brain oxygen saturation (rSO2)
Looking for future studies?
Notify Me20 year–65 year
All sexes
Interventional
Not applicable
Incheon, South Korea
During the laparoscopic cholecystectomy, Pneumoperitoneum could affect to the regional oxygen saturation of brain due to increased intracranial pressure, central venous pressure and make worse to respiratory parameters. Positive end expiratory pressure could improve the respiratory parameters include oxygenation. So applying PEEP could improve the regional oxygen saturation of brain during the pneumoperitoneum during the laparoscopic cholecystectomy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
applying PEEP 0 cmH2O during pneumoperitoneum continuously
Other names: PEEP 0
applying PEEP 10 cmH2O during pneumoperitoneum continuously
Other names: PEEP 10
Time frame: from baseline record rSO2 every 10 minutes
FiO2 0.6, Tidal vlume 8 ml/IBW (kg), PEEP 10 cm H2O or not, respiratory rate as end-tidal carbone dioxide concentration (ETCO2). During the peumoperitoneum record rSO2 every 10 minutes with respiratory parameters (Peak pressure, mean pressure, PEEP) and vital signs
Gachon University Gil Medical Center
Other
The Effect of PEEP on Regional Cerebral Oxygen Saturation During Laparoscopic Cholecystectomy
Acronym: lapaPEEP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT04238260
Behavior, Brain Diseases
Vancouver, British Columbia, Canada
View Trial DetailsNCT03684564
Antiphospholipid Syndrome, Autoimmune Diseases
Epsom, United Kingdom
View Trial DetailsNCT04001049
Brain Diseases, Brain Ischemia
Madrid, Spain
View Trial Details